合計、繰延税金資産、契約解除に伴う清算益他1件
- 【期間】
| 年度 | 合計 | 繰延税金資産 | 契約解除に伴う清算益 | 薬品部門売上高 |
|---|
| 2008/03 | - | | 31.3億 | | - | | 430億 | |
| 2009/03 | - | | 56.8億 | +81.5% | - | | 429億 | -0.3% |
| 2010/03 | - | | 61.8億 | +8.9% | 15.1億 | | 388億 | -9.7% |
| 2011/03 | - | | 83.1億 | +34.3% | - | | 391億 | +0.8% |
| 2012/03 | - | | 80.4億 | -3.3% | - | | 383億 | -1.9% |
| 2013/03 | - | | 77.4億 | -3.7% | - | | 375億 | -2.3% |
| 2014/03 | - | | 65.9億 | -14.9% | - | | - | |
| 2015/03 | - | | 44.2億 | -32.8% | - | | - | |
| 2016/03 | - | | 42.3億 | -4.3% | - | | - | |
| 2017/03 | - | | 42.8億 | +1% | - | | - | |
| 2018/03 | 2408億 | | 32.7億 | -23.6% | - | | - | |
| 2019/03 | 2707億 | +12.4% | 79.3億 | +142.8% | - | | - | |
| 2020/03 | 2588億 | -4.4% | - | | - | | - | |
| 2021/03 | 2796億 | +8% | - | | - | | - | |
| 2022/03 | 3362億 | +20.3% | - | | - | | - | |
| 2023/03 | 3711億 | +10.4% | - | | - | | - | |
